Biopharmaceutics Optimization

Biopharmaceutics Optimization is a biopharmaceutical strategy that systematically enhances the in vivo performance of drug products by improving their oral bioavailability through the rational design of physicochemical and formulation variables.

59

Publications

4.3K

Citations

257

Authors

98

Institutions

Publications per year

2017–2026

26

Authors

257

  1. JL
    Jong‐Hwa Lee

    Korea Institute of Toxicology, South Korea

    2 publications · 46 citations

    2

    h-index

  2. TF
    Talia Flanagan

    AstraZeneca (United Kingdom), United Kingdom

    2 publications · 84 citations

    2

    h-index

  3. RS
    R. S. R. Murthy

    Maharaja Sayajirao University of Baroda, India

    2 publications · 67 citations

    2

    h-index

  4. GL
    Gordon L. Amidon

    University of Michigan, United States

    2 publications · 85 citations

    2

    h-index

  5. AY
    Archit Yajnik

    Maharaja Sayajirao University of Baroda, India

    2 publications · 67 citations

    2

    h-index

1–5 of 257

Venues

  1. Journal of Pharmaceutical Sciences

    7 publications · 627 citations

    7

    h-index

  2. AAPS PharmSciTech

    5 publications · 135 citations

    5

    h-index

  3. International Journal of Nanomedicine

    3 publications · 111 citations

    3

    h-index

  4. International Journal of Pharmaceutics

    3 publications · 189 citations

    3

    h-index

  5. Pharmaceutics

    3 publications · 109 citations

    3

    h-index

1–5